NH-305

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNH-305
Drug Alias Namedopamine D2/D3/5-HT 1a partial agonist (Jiangsu Nhwa Pharmaceutical)NH-305
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D3 receptor agonistsSerotonin 1a (5-HT1a) receptor partial agonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A